البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
TICAGRELOR
K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL
B01AC24
FILM COATED TABLETS
TICAGRELOR 90 MG
PER OS
Required
ADALVO LIMITED, MALTA
TICAGRELOR
Ticagrelor S.K., co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event.Limitations of use: 90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years.
2023-08-27